PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-03-05

Date Title Company
05-Mar-2024 assisTek Celebrates 25 Years of Pioneering Innovation in eClinical Patient Data for Clinical Research Trials AccessWire
05-Mar-2024 Serve You Rx Joins Forces With Mark Cuban Cost Plus Drug Company to Enhance Prescription Affordability for Members AccessWire
05-Mar-2024 Innovaccer's Data Activation Platform Secures the Leading Position as the Premier End-to-End Population Health Solution in the 2024 Black Book User Survey AccessWire
05-Mar-2024 PRODUCTLIFE GROUP ACQUIRES HEALTH CARE SOLUTION (HCS), EXPANDING ITS REACH ACROSS MIDDLE EAST AND AFRICA PRODUCTLIFE GROUP
05-Mar-2024 Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1 AccessWire
05-Mar-2024 3 Years after COVID: Hospitals Nationwide Maintaining Ventilators in Patient-Ready Condition with Support from US Med-Equip AccessWire
05-Mar-2024 HealthJoy Releases Insights From 2024 Member Health Goals Report AccessWire
05-Mar-2024 Radiance Therapeutics to Attend LSI USA '24 Emerging Medtech Summit in Dana Point, CA AccessWire
05-Mar-2024 AGFA HealthCare Appoints AXIM as Strategic Partner in South Africa AccessWire
05-Mar-2024 Gilead Sciences CEO on Company's Evolution and Commitment to the Bay Area AccessWire
05-Mar-2024 Tharimmune to Present at the Emerging Growth Conference on March 7, 2024 AccessWire
05-Mar-2024 Applied Energetics Names James Harrison, Ph.D., as Director of New Product Innovation AccessWire
05-Mar-2024 FREmedica Partners With Pace Creative AccessWire
05-Mar-2024 Biotricity Partners with a Second Top Group Purchasing Organization - Positions Company for Expanded Market Access to 1 out of every 2 Hospitals in America AccessWire
05-Mar-2024 Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update AccessWire
05-Mar-2024 Interventional Cardiology and Vascular Devices Market Poised to Double by 2033, Reaching USD 34 Billion Wired Release
05-Mar-2024 Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic Mainz BioMed N.V.
05-Mar-2024 FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum AccessWire
05-Mar-2024 Bone Health Technologies Secures $5 Million in Funding to Transform Osteopenia Care AccessWire
05-Mar-2024 CLS Holdings Partners with SOMA to Launch Innovative Solventless Cannabis Vape AccessWire